Enhancing Cytokine Stability: How AKTIV-DRY’s Dry Powder Technology Supports IL-2 Therapies
Cytokines, especially Interleukin-2 (IL-2), have become key players in immunotherapy and other biopharmaceutical treatments. As a powerful regulator of immune cell growth and function, IL-2 has shown significant potential in treating cancer, autoimmune diseases, and chronic inflammation. However, one of the main obstacles to the widespread use of IL-2 and other cytokine therapies is stability. AKTIV-DRY, LLC has developed cutting-edge solutions to stabilize these sensitive biological compounds, allowing for enhanced storage, transport, and patient access.
IL-2 in Immunotherapy
IL-2 enhances immune function in cancer treatments by activating cytotoxic T-cells. Its stability during storage is a challenge, and AKTIV-DRY provides a dry powder stabilization solution, ensuring easier storage and transport for clinical use.
🌐 AKTIV-DRY: Engineering the Future of Biologics
AKTIV-DRY, LLC provides cutting-edge micronization and gentle drying solutions for sensitive biologics such as:
- Cytokines (e.g., IL-2, IFNs)
- Antibodies
- Vaccines
- Enzymes and proteins
Applications in Biotech and Pharmaceuticals
The combination of cytokine therapy and dry powder delivery opens new doors in therapeutic design. IL-2 dry formulations may enhance shelf-life, facilitate global distribution, and improve patient accessibility, especially in low-resource settings. Research centers such as the Institut Pasteur and Karolinska Institutet are exploring similar strategies for vaccine and immunotherapy delivery.
AKTIV-DRY, LLC provides dry powder stabilization and processing solutions for the vaccine, pharmaceutical, and biotechnology industries. AKTIV-DRY’s experts have a proven track record in micronizing and gently drying vaccines, antibodies, enzymes, proteins and other pharmaceutical compounds.
AKTIV-DRY engineers particle sizes and morphology to satisfy your requirements. Licenses are available for the patents and intellectual property shown on the page with that name.
To explore how AKTIV-DRY can provide your dry powder solution or discuss equipment or licensing opportunities, email us at aktiv-dry@gentaur.com
Tools to Study Cytokines: An Overview
To study cytokines like IL-2, researchers use multiple categories of tools:
A. Quantification Tools
- ELISA kits (Enzyme-Linked Immunosorbent Assay): Used to measure cytokine levels in blood, serum, or cell culture supernatants.
- Multiplex bead-based assays (e.g., Luminex): Detect multiple cytokines in a single sample.🏛️ University of Oxford (UK) uses ELISA and Luminex to quantify cytokines in vaccine development studies.
B. Antibody-Based Detection
- Monoclonal and polyclonal antibodies: Detect cytokines through Western blot, immunofluorescence, or immunohistochemistry.
- Flow cytometry antibodies: Allow detection of cytokine production at the single-cell level.
C. Gene Expression Tools
- qPCR kits: Measure cytokine mRNA levels, especially for IL-2 and other interleukins.
- RT-PCR arrays: Profile the expression of dozens of cytokine genes simultaneously.🏛️ Max Planck Institute (Germany) uses qPCR arrays to analyze cytokine gene expression in T-cell subsets.
Hepatitis B Stabilization and Drying by CAN-BD
for later reconstitution in pre-filled auto-injectors
Dry vaccines are usually more stable than those dissolved in water. For greater stability, package dry powder vaccines adjacent to the water-for-injection in a single unit-dose auto-reconstitution syringe and mix the dry vaccine with water immediately prior to administration.
The PuffHaler®
AKTIV-DRY Dry Powder Delivery System
AKTIV-DRY, LLC provides dry powder stabilization and processing solutions for the vaccine, pharmaceutical, and biotechnology industries. AKTIV-DRY’s experts have a proven track record in micronizing and gently drying vaccines, antibodies, enzymes, proteins and other pharmaceutical compounds.
AKTIV-DRY engineers particle sizes and morphology to satisfy your requirements. Licenses are available for the patents and intellectual property shown on the page with that name.
